Search
Search
About
Log in
Join
Experiences with
Hepatitis E
Posts
Communities
1,442 public posts
Filter results
FDA Grants Priority Review for AbbVie's Hepatitis C Treatment
AbbVie has announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) and granted priority review for the company's, all-oral, interferon-free, two direct-acting antiviral treatment of ombitasvir, paritaprevir, ritonavir (OBV/PTV/r), with ribavirin (RBV). The
AbbVie has announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) and granted priority review for the company's, all-oral, interferon-free, two direct-acting antiviral treatment of ombitasvir, paritaprevir, ritonavir (OBV/PTV/r), with ribavirin (RBV). The
mwright
in
HFI Connect - Hepatitis
9 years ago
Hepatitis C in Japanby Alan Franciscus
This article which originally appeared in the HCV Advocate, discusses hepatitis C in Japan. Alan FranciscusOf all the industrialized countries of the world, Japan has the highest rate of hepatitis C (HCV). It also has one of the oldest and most varied histories of hepatitis C in the world among the
This article which originally appeared in the HCV Advocate, discusses hepatitis C in Japan. Alan FranciscusOf all the industrialized countries of the world, Japan has the highest rate of hepatitis C (HCV). It also has one of the oldest and most varied histories of hepatitis C in the world among the
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Hepatitis C: Giving a Liver, Getting a Liverby Lucinda Porter
This article from the HCV Advocate discusses issues relating to liver transplantation and organ donation. Years of living with chronic hepatitis C virus infection (HCV) destroyed my friend Rick’s liver. Last year, a liver transplant saved his life. A motor vehicle accident killed a 19-year-old man
This article from the HCV Advocate discusses issues relating to liver transplantation and organ donation. Years of living with chronic hepatitis C virus infection (HCV) destroyed my friend Rick’s liver. Last year, a liver transplant saved his life. A motor vehicle accident killed a 19-year-old man
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Want to take advantage of all our features? Just log in!
Log in
or
Join
Harvoni Beats Hep C Among Those With Advanced Liver Disease
Gilead Sciences’ Harvoni (ledipasvir/sofosbuvir) and ribavirin cures hepatitis C virus (HCV) at mostly high rates among those with decompensated cirrhosis or who have had recurrent hep C after a liver transplant, MedPage Today reports. Researchers in the SOLAR-2 trial gave 12 or 24 weeks of the regimen
Gilead Sciences’ Harvoni (ledipasvir/sofosbuvir) and ribavirin cures hepatitis C virus (HCV) at mostly high rates among those with decompensated cirrhosis or who have had recurrent hep C after a liver transplant, MedPage Today reports. Researchers in the SOLAR-2 trial gave 12 or 24 weeks of the regimen
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Joint Pain Flares Among People With HIV, Hepatitis C or Both
People with HIV or hepatitis C virus (HCV), or who are coinfected with both viruses, report high levels of joint pain, aidsmap reports. Publishing their findings in BMC Musculoskeletal Disorders, researchers conducted a cross-sectional study in which they interviewed 202 participants about joint pain
People with HIV or hepatitis C virus (HCV), or who are coinfected with both viruses, report high levels of joint pain, aidsmap reports. Publishing their findings in BMC Musculoskeletal Disorders, researchers conducted a cross-sectional study in which they interviewed 202 participants about joint pain
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Daclatasvir and Sovaldi Cure High Rates of Genotype 1 of Hep C
A recent trial suggests that Bristol-Myers Squibb’s daclatasvir plus Gilead Sciences’ Sovaldi (sofosbuvir), with or without ribavirin, cures high rates of people with genotype 1 of hepatitis C virus (HCV), including those with cirrhosis. Preliminary results from the trial were reported at the 50th International
A recent trial suggests that Bristol-Myers Squibb’s daclatasvir plus Gilead Sciences’ Sovaldi (sofosbuvir), with or without ribavirin, cures high rates of people with genotype 1 of hepatitis C virus (HCV), including those with cirrhosis. Preliminary results from the trial were reported at the 50th International
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Could a Cancer Drug Cure Hepatitis B?
A cancer drug has shown promise as a potential cure for hepatitis B virus (HBV). Publishing their findings in the Proceedings of the National Academy of Sciences, Australian researchers studied the effects of a combination treatment on hep B-infected liver cells, using the antiviral drug entecavir and
A cancer drug has shown promise as a potential cure for hepatitis B virus (HBV). Publishing their findings in the Proceedings of the National Academy of Sciences, Australian researchers studied the effects of a combination treatment on hep B-infected liver cells, using the antiviral drug entecavir and
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Harvoni Beats Hep C Among Those With Advanced Liver Disease
Gilead Sciences’ Harvoni (ledipasvir/sofosbuvir) and ribavirin cures hepatitis C virus (HCV) at mostly high rates among those with decompensated cirrhosis or who have had recurrent hep C after a liver transplant, MedPage Today reports. Researchers in the SOLAR-2 trial gave 12 or 24 weeks of the regimen
Gilead Sciences’ Harvoni (ledipasvir/sofosbuvir) and ribavirin cures hepatitis C virus (HCV) at mostly high rates among those with decompensated cirrhosis or who have had recurrent hep C after a liver transplant, MedPage Today reports. Researchers in the SOLAR-2 trial gave 12 or 24 weeks of the regimen
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
How many times have you told your story?
You’ve told your hepatitis story a million times. Now, tell it to those who can do something to help cure it. Act now by taking the HepPRN survey. http://www.hepatitisfoundation.org/RESEARCH/Patient_Registry.html You have you told your story in support groups, to doctors, to family and others.
You’ve told your hepatitis story a million times. Now, tell it to those who can do something to help cure it. Act now by taking the HepPRN survey. http://www.hepatitisfoundation.org/RESEARCH/Patient_Registry.html You have you told your story in support groups, to doctors, to family and others.
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
May 2015 Is National Hepatitis Awareness Month
In observance of National Hepatitis Awareness Month, which takes place every May, the U.S. government is once again working to increase knowledge of the hepatitis C virus (HCV) and hepatitis B virus (HBV), which together affect between 3.5 million and 5.3 million Americans, according to AIDS.gov. Continue
In observance of National Hepatitis Awareness Month, which takes place every May, the U.S. government is once again working to increase knowledge of the hepatitis C virus (HCV) and hepatitis B virus (HBV), which together affect between 3.5 million and 5.3 million Americans, according to AIDS.gov. Continue
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Update on my hep C treatment
Hi all. Here is an update on my Hep C treatment. I am on the new treatment of Sofosbuvir/Ledpasvir and Ribavirin. I started this treatment on 1st April 2015, I had my liver transplant August 2013, and here are my blood results from the start to now. -- 01/04/15 - Hep C Viral load = over 58 Million, 2
Hi all. Here is an update on my Hep C treatment. I am on the new treatment of Sofosbuvir/Ledpasvir and Ribavirin. I started this treatment on 1st April 2015, I had my liver transplant August 2013, and here are my blood results from the start to now. -- 01/04/15 - Hep C Viral load = over 58 Million, 2
dizzime
in
British Liver Trust
9 years ago
Options for Treating Hepatitis C in Those With Advanced Cirrhosis
Various combinations of Sovaldi (sofosbuvir), Olysio (simeprevir) and ribavirin have shown moderate promise in curing people with genotype 1 or 2 of hepatitis C virus (HCV) who have decompensated cirrhosis. Researchers presented preliminary findings from the HCV-TARGET study at the 50th International
Various combinations of Sovaldi (sofosbuvir), Olysio (simeprevir) and ribavirin have shown moderate promise in curing people with genotype 1 or 2 of hepatitis C virus (HCV) who have decompensated cirrhosis. Researchers presented preliminary findings from the HCV-TARGET study at the 50th International
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Merck’s Hep C Meds Work Well in Treatment-Experienced People
Twelve weeks of Merck’s grazoprevir and elbasvir, plus ribavirin, cured nearly all treatment-experienced people with genotype 1 of hepatitis C virus (HCV) in a small trial, including those with cirrhosis. The Phase II C-SALVAGE trial included 79 people who had failed a previous regimen of interferon,
Twelve weeks of Merck’s grazoprevir and elbasvir, plus ribavirin, cured nearly all treatment-experienced people with genotype 1 of hepatitis C virus (HCV) in a small trial, including those with cirrhosis. The Phase II C-SALVAGE trial included 79 people who had failed a previous regimen of interferon,
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Hepatitis C in the News
There are two annual meetings that concentrate on liver disease, which includes hepatitis C infection. The fall meeting takes place in the U.S., and the spring meeting occurs in Europe. The European Association for the Study of the Liver (EASL) hosts the spring meeting, called the International Liver
There are two annual meetings that concentrate on liver disease, which includes hepatitis C infection. The fall meeting takes place in the U.S., and the spring meeting occurs in Europe. The European Association for the Study of the Liver (EASL) hosts the spring meeting, called the International Liver
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
MSD Announces Results from Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy
Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease C-SURFER Trial is First to Investigate an All-Oral Ribavirin-Free Hepatitis C Treatment Regimen in Treatment-Naïve and Treatment-Experienced Patients with Advanced Chronic Kidney Disease Infected with Hepatitis C Virus Genotype 1
Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease C-SURFER Trial is First to Investigate an All-Oral Ribavirin-Free Hepatitis C Treatment Regimen in Treatment-Naïve and Treatment-Experienced Patients with Advanced Chronic Kidney Disease Infected with Hepatitis C Virus Genotype 1
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
SEEKING PARTICIPATION IN HFI PATIENTADVISORY COUNCIL ***COMPENSATION PROVIDED***
HFI is participating in the PRIHME Study (Comparative Effectiveness of Primary Care-based Hepatitis C Treatment Models to Increase Access in Hard-to-Reach Populations) Which is a research focused intervention to support the care of hard-to-treat patients with chronic hepatitis C (HCV) infection. As a
HFI is participating in the PRIHME Study (Comparative Effectiveness of Primary Care-based Hepatitis C Treatment Models to Increase Access in Hard-to-Reach Populations) Which is a research focused intervention to support the care of hard-to-treat patients with chronic hepatitis C (HCV) infection. As a
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Cancer rates among patients with hepatitis C are increased compared to those not infected
Researchers suggest an extrahepatic manifestation of hepatitis C may be an increased risk of cancer European Association for the Study of the Liver April 24, 2015, Vienna , Austria: Results announced today at The International Liver CongressTM 2015 show that cancer rates in patients with the hepatitis
Researchers suggest an extrahepatic manifestation of hepatitis C may be an increased risk of cancer European Association for the Study of the Liver April 24, 2015, Vienna , Austria: Results announced today at The International Liver CongressTM 2015 show that cancer rates in patients with the hepatitis
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
AbbVie Presents Late-Breaking, Preliminary Phase 3b Data with VIEKIRAX® + EXVIERA®
AbbVie Presents Late-Breaking, Preliminary Phase 3b Data with VIEKIRAX® + EXVIERA® in Chronic Hepatitis C Patients with Renal Impairment at The International Liver Congress™ 2015 http://hepatitiscresearchandnewsupdates.blogspot.com/2015/04/merck-announces-presentation-of-phase-2.html
AbbVie Presents Late-Breaking, Preliminary Phase 3b Data with VIEKIRAX® + EXVIERA® in Chronic Hepatitis C Patients with Renal Impairment at The International Liver Congress™ 2015 http://hepatitiscresearchandnewsupdates.blogspot.com/2015/04/merck-announces-presentation-of-phase-2.html
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Indiana HIV Outbreak, Hepatitis C Epidemic Sparks CDC Alert
An Indiana county is experiencing nearly daily increases in new HIV infections tied to intravenous drug use, and health officials hope the situation prompts other states to closely track their hepatitis C and HIV rates to identify potential clusters of the diseases. Indiana state health officials said
An Indiana county is experiencing nearly daily increases in new HIV infections tied to intravenous drug use, and health officials hope the situation prompts other states to closely track their hepatitis C and HIV rates to identify potential clusters of the diseases. Indiana state health officials said
mwright
in
HFI Connect - Hepatitis
9 years ago
Rapid HCV Test Approved In Europe
Cepheid recently announced that its quantitative hepatitis C virus infection viral load test, Xpert HCV Viral Load, has achieved CE-IVD status under the European Directive on In Vitro Diagnostic Medical Devices. The test received approval as a medical device and will enable HCV viral load to be monitored
Cepheid recently announced that its quantitative hepatitis C virus infection viral load test, Xpert HCV Viral Load, has achieved CE-IVD status under the European Directive on In Vitro Diagnostic Medical Devices. The test received approval as a medical device and will enable HCV viral load to be monitored
mwright
in
HFI Connect - Hepatitis
9 years ago
1
...
59
60
61
...
73
Next page
20
30
40
50
60
70
Filter results
Clear filters
Posted in
All communities
British Liver Trust
353 results
HFI Connect - Hepatitis
225 results
PBC Foundation
94 results
View top 10 communities
Sort by
Most Relevant
Newest